Clinical characteristics of different histologic types of breast cancer

British Journal of Cancer

Volumn 93, Issue 9, 2005, Pages 1046-1052

  Li, C I ^a   Uribe, D J ^a   Daling, J R ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Breast carcinoma; Histology; Oestrogen receptor; SEER; Stage

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; BREAST PAPILLOMA; CANCER REGISTRY; CANCER SIZE; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDULLARY CARCINOMA; MUCINOUS CARCINOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; RACE DIFFERENCE;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, PAPILLARY; FEMALE; HUMANS; LYMPH NODES; MIDDLE AGED; NEOPLASMS, DUCTAL, LOBULAR, AND MEDULLARY; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SEER PROGRAM;

EID: 27644467501     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602787     Document Type: Article

References (26)

1. Anderson WF, Chu KC, Chang S (2003) Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities? J Clin Oncol 21: 2254-2259
2. Anderson WF, Chu KC, Chang S, Sherman ME (2004) Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev 13: 1128-1135
3. Arpino G, Bardou VJ, Clark GM, Elledge RM (2004) Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 6: R149-R156
4. Begg CB, Gray R (1984) Calculation of polychotomous logistic regression parameters using individualized regressions. Biometrika 71: 11-18
5. Bernstein L (1998) The epidemiology of breast cancer. Women Cancer 1S: 7-13
6. Chen CL, Weiss NS, Newcomb P, Barlow W, White E (2002) Hormone replacement therapy in relation to breast cancer. JAMA 287: 734-741
7. Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Marchbanks PA, Coates RJ, Norman SA, Weiss LK, Ursin G, Burkman RT, Deapen D, Folger SG, McDonald JA, Simon MS, Strom BL, Spirtas R (2003) Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years. Cancer Epidemiol Biomarkers Prev 12: 1175-1181
8. Davis RP, Nora PF, Kooy RG, Hines JR (1979) Experience with lobular carcinoma of the breast. Emphasis on recent aspects of management. Arch Surg 114: 485-488
9. Desai SB, Moonim MT, Gill AK, Punia RS, Naresh KN, Chinoy RF (2000) Hormone receptor status of breast cancer in India: a study of 798 tumours. Breast 9: 267-270
10. Dixon JM, Anderson TJ, Page DL, Lee D, Duffy SW (1982) Infiltrating lobular carcinoma of the breast. Histopathology 6: 149-161
11. Korhonen T, Huhtala H, Holli K (2004) A comparison of the biological and clinical features of invasive lobular and ductal carcinomas of the breast. Breast Cancer Res Treat 85: 23-29
12. Li CI, Anderson BO, Daling JR, Moe RE (2003a) Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 289: 1421-1424
13. Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Cushing-Haugen KL, Daling JR (2003b) Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA 289: 3254-3263
14. Li CI, Moe RE, Daling JR (2003c) Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years. Arch Intern Med 163: 2149-2153
15. Li CI, Weiss NS, Stanford JL, Daling JR (2000) Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women. Cancer 88: 2570-2577
16. Mathieu MC, Rouzier R, Llombart-Cussac A, Sideris L, Koscielny S, Travagli JP, Contesso G, Delaloge S, Spielmann M (2004) The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile. Eur J Cancer 40: 342-351
17. Morabia A, Flandre P (1992) Misclassification bias related to definition of menopausal status in case-control studies of breast cancer. Int J Epidemiol 21: 222-228
18. Newcomb PA, Titus-Ernstoff L, Egan KM, Trentham-Dietz A, Baron JA, Storer BE, Willett WC, Stampfer MJ (2002) Postmenopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev 11: 593-600
19. Newcomer LM, Newcomb PA, Potter JD, Yasui Y, Trentham-Dietz A, Storer BE, Longnecker MP, Baron JA, Daling JR (2003) Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States). Cancer Causes Control 14: 225-233
20. Silverstein MJ, Lewinsky BS, Waisman JR, Gierson ED, Colburn WJ, Senofsky GM, Gamagami P (1994) Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer 73: 1673-1677
21. Stalsberg H, Thomas DB (1993) Age distribution of histologic types of breast carcinoma. Int J Cancer 54: 1-7
22. Stierer M, Rosen H, Weber R, Hanak H, Spona J, Tuchler H (1993) Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors. Ann Surg 218: 13-21
23. Surveillance Epidemiology and End Results, National Cancer Institute (2005a) SEER data quality, available at http://seer.cancer.gov/about/quality. html (accessed April 27, 2005)
24. Surveillance Epidemiology and End Results, National Cancer Institute (2005b) Characteristics of the SEER population compared with the total United States population, available at http://www.seer.cancer.gov/registries/ characteristics.html (accessed April 27, 2005)
25. Yeatman TJ, Cantor AB, Smith TJ, Smith SK, Reintgen DS, Miller MS, Ku NN, Baekey PA, Cox CE (1995) Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg 222: 549-559
26. Young Jr JL, Percy CL, Asire AJ (1981) Surveillance, epidemiology, and end results: incidence and mortality, 1973-77. Natl Cancer Inst Monogr 57: 1-1082